Sample6 Secures Financing to Commercialize Food Safety Products
Sample6, a Boston-based company focused on applying biotechnology to advance food safety, announced today that it has secured a $11 million Series B financing round led by Canaan Partners. Joining the round are Cultivian Sandbox, a fund that invests in emerging technologies in the food and agriculture industry, and Series A lead investor Flybridge Capital Partners. In addition, the company noted that Stephen Bloch, MD, general partner of Canaan Partners, has joined its Board of Directors while Peter Farina, PhD, executive in residence for Canaan Partners, will join its Scientific Advisory Board.
The funds will be used to commercialize Sample6's first products, Sample6 DETECT/L and Sample6 CONTROL, which are designed to enable in-plant, in-shift pathogen detection in food processing environments. Sample6 DETECT/L is the company's first diagnostic assay and is designed to identify Listeria contamination. Sample6 CONTROL is the company's software platform, which is used by food companies to plan, execute, remediate and analyze food safety programs.